Heather Morel, MBA
Advertisement
Articles by Heather Morel, MBA
REMS programs in acute and chronic pain management continue to evolve to reduce risk associated with pain medications.
REMS programs in acute and chronic pain management continue to evolve to reduce risk associated with pain medications.
What each stakeholder needs to know about REMS in today's fast-paced climate.
Advertisement
Latest Updated Articles
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: March 24th 2011 | Updated:
The Changing Landscape of REMS in Pain ManagementPublished: November 18th 2011 | Updated:
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: October 12th 2010 | Updated:
- REMS in Pain Management
Published: December 5th 2011 | Updated:
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: December 5th 2011 | Updated:
- REMS in Pain Management
Published: November 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
2
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
3
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
4
SGLT2 Inhibitors Linked to Lower Atrial Fibrillation Risk, Recurrence
5
